Real-world evaluation of the transition between originator and follow-on glatiramer acetate in people with multiple sclerosis: the “GA transition” study

20260 citationsJournal Articlehybrid Open Access

Authors

Irene Schiavetti · University of Genoa

Pietro Annovazzi · Associazione Italiana Sclerosi Multipla

Cinzia Cordioli · Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Mattia Pozzato · Associazione Italiana Sclerosi Multipla

Sarah Rasia · Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Elisabetta Signoriello · University of Campania "Luigi Vanvitelli"

Abstract

Switching from originator GA to CO did not influence clinical outcomes or safety. These findings support the therapeutic equivalence of the two formulations in real-world clinical practice, by supporting previous evidence from randomized trials.

Topics & Keywords

Multiple Sclerosis Research Studies Amyotrophic Lateral Sclerosis Research Peripheral Neuropathies and Disorders

Publication Details

Published in: Multiple Sclerosis and Related Disorders

Volume 109, pp. 107088-107088

DOI: 10.1016/j.msard.2026.107088

Field-Weighted Citation Impact: 0.00

Command Palette

Real-world evaluation of the transition between originator and follow-on glatiramer acetate in people with multiple sclerosis: the “GA transition” study

Authors

Abstract

Topics & Keywords

Publication Details